Rentokil Initial plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RTO research report →
Range $26.7 – $26.7
Price Chart
About the company
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific. The company offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management. It provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
- CEO
- Michael A. Duffy Jr.
- IPO
- 1996
- Employees
- 63,388
- HQ
- Crawley, WSX, GB
Get TickerSpark's AI analysis on RTO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $12.05B
- P/E
- 26.02
- Fwd P/E
- 22.77
- PEG
- 0.65
- P/S
- 1.51
- P/B
- 2.23
- EV/EBITDA
- 9.65
- Div Yield
- 2.56%
- Gross Margin
- 72.11%
- Op Margin
- 12.13%
- Net Margin
- 3.92%
- ROE
- 5.82%
- ROIC
- 5.68%
Latest fiscal year · YoY change
- Revenue
- $6.91B+27.2%
- Gross Profit
- $2.27B+212.3%
- Op Income
- $945.89M
- Net Income
- $470.44M+53.2%
- EPS
- $0.95+58.3%
- OCF Growth
- +44.2%
- FCF Growth
- +51.8%
- 52W High
- $34.67
- 52W Low
- $19.50
- 50D MA
- $21.96
- 200D MA
- $27.83
- Beta
- 0.41
- RSI (14)
- 61
- Avg Volume
- 1.76M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Rentokil reported solid first-half growth and cash generation, while signaling a deeper U.S. restructuring focus and dropping its prior North America 20% margin target.· July 30, 2026
- Half-year revenue rose 4.5% to $3.589 billion, organic growth was 3.6%, operating profit increased 6.6% to $556 million, and EPS grew 8.3%.
- Free cash flow conversion was 96% and leverage improved to 2.4x, back within the 2.0x-2.5x target range.
- North America revenue grew 4.2% to $2.197 billion and operating profit rose 10.2% to $393 million, but commercial growth lagged while residential remained stronger.
- Management retired the 2027 North America 20% margin target, saying savings will be reinvested into growth and the business is likely to remain in transition for some time.
- International organic growth improved to 4.2% in Q2, with pest control at 5.4% organic growth in the quarter, and management said there is still more efficiency potential across the group.
Half year revenue was $3.589 billion, up 4.5%, with organic revenue growth of 3.6%. Operating profit was $556 million, up 6.6%, and operating margin was 15.5%, up 30 basis points. Earnings per share grew 8.3%; free cash flow conversion was 96%, versus 93% last year. North America revenue rose 4.2% to $2.197 billion, operating profit increased 10.2% to $393 million, and margin improved to 17.9%. International revenue increased 5.0% to $1.392 billion, operating profit rose 4.3% to $266 million, and margin was 19.1%. For the full year, management said it remains on track for greater than 80% cash conversion and expects full year profit in line with current market expectations, with no change to outlook. Central costs were up 16.9% and are expected to moderate in the second half, with full-year growth in the low double digits. The company increased the interim dividend by 8%.
Michael Duffy framed the quarter as proof that the business has a strong “right to win,” but said the company is too complex and not yet consistently organized to convert that into full organic growth. He emphasized three priorities: customer focus, sales and operational excellence, and business simplification, and said the goal is to make the frontline easier to support and enable more consistent execution. His tone was confident but candid, especially on North America, where he said the team needs to shift from triaging integration issues to building a more sustainable growth plan.
Paul Edgecliffe-Johnson highlighted the hard numbers: revenue of $3.589 billion, operating profit of $556 million, 15.5% margin, EPS growth of 8.3%, and free cash flow conversion of 96%. In North America, margin reached 17.9%, helped by over 1,100 roles moved offshore and over 500 roles eliminated through process redesign and automation; those actions produced $45 million of gross savings in the half and $28 million net after reinvestment, with a gross savings run rate of around $90 million annualized. He also noted leverage at 2.4x, net debt down $75 million, one-off and adjusting items cash impact of $70 million in the half, full-year guidance of $110 million to $120 million for those items, reduced full-year M&A spend to $120 million, and increased termite provision cash outflow guidance to $115 million to $125 million.
Analysts focused heavily on the U.S. restructuring plan, including how long it may take and whether the North America commercial business was mishandled during integration. Management said the turnaround could take about 2 years in parts of the business, but progress should be steady along the way, and they stressed that residential and commercial need separate focus, systems and accountability. Questions also pushed on the weaker residential lead flow in late Q2 and July; management attributed that mostly to softer termite leads and some housing-market pressure in certain geographies, while saying there are still internal fixes to improve conversion and onboarding. On M&A and simplification, management said lower M&A spend reflects being more selective on targets and IRR, not a cash constraint, and that any portfolio exits would be selectively disclosed if they occur.
The company is still growing, with first-half revenue, operating profit, EPS and cash conversion all improving year over year. Management believes the North America playbook is working in residential and says there is meaningful additional upside from commercial focus, simplified operations, and further cost savings that can be reinvested into growth. International pest growth also accelerated in Q2, and the group ended the half with leverage back inside its target range.
North America commercial growth was weaker, residential lead flow softened late in Q2 and into July, and management acknowledged the business is still too complex and inconsistent. The company also retired its 2027 North America 20% margin target, signaling that near-term reinvestment and organizational change will dilute margins before growth benefits fully show up. The termite provision was increased, and management said some of the longer-running changes could take up to 2 years to fully implement.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.6%
- Shares Outstanding
- 503.08M
- Float Shares
- 496.22M
Congressional trading
Senate and House stock disclosures for RTO, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Held by 44 ETFs
Biggest fund positions in RTO by dollar value.
Our RTO coverage
Recent articles, reports, and earnings notes.
Want a deeper read on RTO?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Rentokil: Need More Excitement In 2027 To Change My Mind
seekingalpha.com · Nov 17
Parnassus Mid Cap Fund Q3 2026 Portfolio Review
seekingalpha.com · Oct 28
Beyond the Bait Box: Rentokil Commercial State of the Rodent Report Reveals Modern Playbook for Businesses
globenewswire.com · Oct 28
Rentokil Initial PLC $RTO Stock: Iridian Asset Management LLC CT Raises Holdings
defenseworld.net · Oct 25
Rentokil: KPIs Are Heading In The Right Direction
seekingalpha.com · Oct 24
Rentokil's price target raised by UBS as North America shows signs of stabilising
proactiveinvestors.com · Oct 23
Rentokil Initial plc (RTO) Q3 2026 Sales/Trading Call Transcript
seekingalpha.com · Oct 22
What Rentokil Initial (RTO) Said on Its Q3 Earnings Call
marketbeat.com · Oct 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
